Related Experiment Video
Updated: Apr 4, 2026
07:44
An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants
Published on: May 22, 2020
28.6K
Altered neuronal network and rescue in a human MECP2 duplication model.
S Nageshappa1, C Carromeu2,3, C A Trujillo2,3
1Department of Human Genetics, Laboratory for the Genetics of Cognition, Center for Human Genetics, KU Leuven, Leuven, Belgium.
Molecular Psychiatry
|September 9, 2015
Summary
Increased dosage of methyl-CpG-binding protein-2 (MeCP2) causes severe neurodevelopmental issues. Researchers used patient stem cells to find a potential drug, NCH-51, that may reverse these effects in MECP2 duplication syndrome.
Area of Science:
- Neuroscience
- Genetics
- Stem Cell Biology
Background:
- Overexpression of methyl-CpG-binding protein-2 (MeCP2) causes severe neurodevelopmental disorders.
- The MECP2 duplication syndrome (MECP2dup) is characterized by increased MeCP2 dosage and presents at birth.
Purpose of the Study:
- To investigate the impact of elevated MeCP2 levels on human neurons using patient-derived induced pluripotent stem cells (iPSCs).
- To identify potential therapeutic interventions for MECP2dup by screening epigenetic compounds.
Main Methods:
- Generation of iPSCs from MECP2dup patients with varying duplication sizes.
- Differentiation of iPSCs into cortical neurons for functional analysis.
- Assessment of synaptogenesis, dendritic complexity, and neuronal network synchronization using multi-electrode arrays.
- Screening of epigenetic compounds for therapeutic potential.
Main Results:
- MECP2dup-derived neurons exhibited increased synaptogenesis and dendritic complexity.
- Neuronal network synchronization was altered in MECP2dup neurons.
- The histone deacetylase inhibitor NCH-51 demonstrated potential to reverse MECP2dup-associated alterations.
Conclusions:
- Patient-derived iPSC models accurately recapitulate early MECP2dup phenotypes.
- NCH-51 represents a novel therapeutic candidate for MECP2dup.
- This cellular model provides a platform for drug discovery in severe neurodevelopmental disorders.
